Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.05 USD
Change Today -0.0001 / -0.19%
Volume 600.0
STEV On Other Exchanges
As of 9:30 AM 10/5/15 All times are local (Market data is delayed by at least 15 minutes).

stevia corp (STEV) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/8/14 - $0.10
52 Week Low
07/13/15 - $0.04
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for STEVIA CORP (STEV)

Related News

No related news articles were found.

stevia corp (STEV) Related Businessweek News

No Related Businessweek News Found

stevia corp (STEV) Details

Stevia Corp. provides various farm management services primarily to contract growers. Its farm management services include training the farmers on the correct protocols and methodologies; and providing ongoing technical assistance during the crop cycle, as well as inputs, such as the seedlings, fertilizers, and additives that are required to use. Stevia Corp. also focuses on the commercial development of natural products that support healthy lifestyle, including stevia, hemp, and their extracts. The company was formerly known as Interpro Management Corp. and changed its name to Stevia Corp. in March 2011. Stevia Corp. was incorporated in 2007 and is based in Indianapolis, Indiana.

1 Employees
Last Reported Date: 07/15/14
Founded in 2007

stevia corp (STEV) Top Compensated Officers

President, Treasurer, Secretary and Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

stevia corp (STEV) Key Developments

Stevia Corp. announced delayed annual 10-K filing

On 06/30/2015, Stevia Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Stevia Corp. announced delayed 10-Q filing

On 02/17/2015, Stevia Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Stevia Corp. Files Two Additional Provisional Patent Applications with the United States Patent and Trademark Office for the Treatment of Pain and Cardiovascular Disease

Stevia Corp. announced the filing of two additional provisional patent applications with the United States Patent and Trademark Office (USPTO) for the treatment of pain and cardiovascular disease. The two separate applications include a provisional patent application that contains a formulation of naproxen and cannabidiol (CBD) and another application that contains a formulation of aspirin and cannabidiol. Stevia Corp. has now filed four provisional patent applications with the USPTO for four of the large selling generic pain killing medications worldwide in combination with CBD. All four provisional patent applications were filed with the assistance of an intellectual property attorney with extensive experience in the healthcare industry. A provisional patent application is a legal document which establishes an early priority date for the benefit of claiming 'first to file' status against other companies or individuals that may want to file a patent with similar claims after the filing date of the provisional patent. Naproxen is a non-steroidal anti-inflammatory drug used to treat both pain and inflammation. Although the mechanism of action of NSAIDs such as naproxen are not completely understood, they are believed to work by inhibiting the synthesis of prostaglandins which are fat-like molecules that are involved in mediating inflammation, pain and fever. It achieves this synthesis by inhibiting cyclooxygenase, an enzyme that is present in various tissues of the body. Aspirin is a painkiller and an anti-inflammatory agent with a long history of safe use. Aspirin is also frequently prescribed to individuals that have experienced an adverse cardiac event such as myocardial infarction. Furthermore, aspirin is used for the prevention of cardiac disease. Aspirin works for pain care and inflammation by inhibiting the synthesis of prostaglandins, which are fat-like molecules that are involved in mediating inflammation, pain and fever. Aspirin also has an antiplatelet effect by inhibiting the production of thromboxane. Under normal circumstances, thromboxane binds platelet molecules together to create a patch over a damaged section of a blood vessel. If and when the platelet patch becomes too large, it can restrict blood flow resulting in a heart attack or stroke. If atherosclerosis is present or an individual's family has a history of heart disease, a daily dose of aspirin may be prescribed after a heart attack or to prevent another heart attack. In many cases, a daily dose of aspirin is prescribed for the prevention and management of signs of cardiovascular disease. Cannabidiol (CBD) is a cannabinoid that is present in most varieties of the cannabis sativa and cannabis indica plants. Cannabinoids are unique to the cannabis sativa and cannabis indica plants. Unlike some of the other molecules found in varieties of the cannabis plant, it is non-psychoactive and it is not believed to have any addictive properties. It is also extremely well tolerated at high doses with little or no adverse side effects. Cannabidiol catapulted into a national story after being an important part of the 2013 CNN documentary 'Weed'.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STEV:US $0.05 USD -0.0001

STEV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for STEV.
View Industry Companies

Industry Analysis


Industry Average

Valuation STEV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book 3.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STEVIA CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at